BriaCell’s Bria-ABC Joins Roster of US-Enrolled Breast Cancer Trials
BriaCell Therapeutics’ (TSX:BCT,NASDAQ:BCTX) Phase 3 Bria-ABC study has been included in a roundup of breast cancer…
Read More...
Read More...
Finance News